Lisata Therapeutics Inc LSTA

US Biotechnology

$0.99 ▼ -3.88% ($-0.04)

⚡ High Volume 🎈 Low Float 📅 Earnings This Week

Open $1.04

Prev Close $1.03

Day Range $0.99 – $1.08

52W Range $0.99 – $5.07

Market Cap $9.02M

Beta 0.87

EPS (TTM) $-1.91

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	1995-11-03
Shares Out.	9,110,000
Website	lisata.com/ ↗
Phone	19082292590
Employees	21
Net Income	-$4.5M
Free Cash Flow	-$13.6M
Total Assets	$14.1M
Total Liabilities	$3.4M
Equity	$10.7M

About Lisata Therapeutics Inc

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Lisata Therapeutics Inc is a publicly traded company under the ticker symbol LSTA on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.